DOTS Technology Corp

About DOTS Technology Corp

DOTS Technology Corp., also known as Detection On The Spot (DOTS), was established in 2013 and is a health-tech company based in Natick, Massachusetts. The company is developing a point-of-care diagnostics platform with applications for both consumers and various industries. A primary focus for the company is creating a food allergen detection system that allows consumers to test food on the spot, aiming to improve the quality of life for individuals with food allergies. This system is based on the company's Detection On the Spot diagnostics platform, which utilizes protein-specific signaling molecules called signaling polynucleotides to identify the presence of food allergens.

The company was co-founded by Renuka Babu and Adi Gilboa-Geffen. Renuka Babu, who serves as the CEO, has a background in both biotech and financial start-ups, having held leadership roles at companies like the RiskMetrics Group (now MSCI) and ArQule (ARQL). She also has experience in commercializing intellectual property from her time as Executive Director of New Ventures at Boston University. Adi Gilboa-Geffen is the company's Co-Founder and Chief Scientific Officer.

DOTS Technology Corp. operates as a privately held, venture-capital-funded company. It has engaged in several funding rounds, including a significant Series B round. As a developer of its diagnostic platform, the company holds numerous patents for its technology. The business model appears to be centered on the development and eventual sale of its diagnostic devices and related technologies to consumers and industrial clients. The firm has received investments from institutional investors such as New Enterprise Associates, EQT, and Felicis Ventures.